CureSearch

Help CureSearch win $100,000 by voting for Gregg in the NASCAR BJF Humanitarian Award! He’s doing this for his granddaughter, Violet, and for every kid facing cancer. You can vote daily here: nascarfoundation.org/award @NASCAR #voteforgregg

Kids fighting cancer deserve more than a fraction of the funding - and that's why CureSearch is filling the gap. We're driving the research needed to bring better treatments to children, faster.

Because of you, this year has been filled with hope and lifesaving progress. Thank you for standing with us to end children’s cancer. 💛

ATRT is a very tough-to-treat pediatric brain tumor, but Dr. Prensner is exploring something entirely new to uncover new ways to treat the disease. Read more about this groundbreaking project made possible by your support: curesearch.org/unlocking-hope…

We’re proud to fund Dr. John Prensner’s groundbreaking research on ATRT, a rare and aggressive pediatric brain tumor. He’s exploring tiny DNA pieces, once overlooked, that could unlock targeted treatments. Thank you for supporting bold, life-changing science!

To everyone who supported CureSearch this #GivingTuesday—thank you! 💛 Your generosity fuels lifesaving childhood cancer research and gives kids and families brighter tomorrows. Together, we’re making a difference. 🌟 #ChildhoodCancer

Time is running out to fund new breakthroughs in pediatric cancer research. Donate now! give.curesearch.org/campaign/62612… #GivingTuesday2024 #GivingTuesday

Amazing insights at #PEDS2024 today! From breaking down barriers between industries to harnessing collective expertise, it's clear that collaboration is key. Thank you to our first-day speakers, and we look forward to tomorrow!

#pediatriccancer #drugdevelopment #peds

2024 PEDS speaker highlight: "It's going to take a village and an ecosystem that collaborates like never before. But I believe we will get to the finish line." - Surajit Sen, EY-Parthenon #pediatriccancer #drugdevelopment #peds

A huge thank you to @mycarolinacbs17 for having two of our incredible Triangle Area Community Board members on air to share CureSearch’s mission to end childhood cancer. Don’t forget, our Umstead CureSearch Hike is coming up on October 19th!

During an incredibly heartfelt evening, volunteers shared their personal stories and reflected on their involvement with #CureSearch. We were delighted to honor a select group of individuals at our first annual CureSearch Volunteer Awards ceremony. #curesearchsummit

Today, we're thrilled to announce our latest funded project led by Dr. @MoAbdelbaki at Washington University in St. Louis aiming to change the treatment landscape for these tumors. @WashUPeds Read more about this Phase I clinical trial: curesearch.org/.../clinical..…

We are thrilled to share that Dr. Samuel Blackman will be the speaker at this year's PEDS Session 2, discussing “If You Build It, Will They Come? How Can We Build the Case for Investing in Pediatric Cancer Drug Development?”

It only takes one moment for a life to change forever. For Helen Jonsen that moment was when her 9 year old daughter, Clare, was diagnosed with osteosarcoma. It takes one small step to join us in changing the lives of children facing a cancer diagnosis. curesearch.org/donate

Your dollars fund truly impactful change for kids with cancer. Thank YOU for being the driving force behind our mission!

We are thrilled to announce this very exciting, bi-continental collaboration with the esteemed UK-based medical research charity LifeArc. Your support is instrumental in driving this impactful research, offering hope to children across the world.

In a groundbreaking development for pediatric Ewing sarcoma research, we're thrilled to announce our latest funded project led by Dr. John Lee of UCLA. His team's research offers hope for a new, precise treatment for this aggressive disease. curesearch.org/dr-lees-missio…

During #BrainTumorAwarenessMonth, we’re committed to shining a light on the profound impact the disease has on children and their families, and the crucial need for more research, treatment options, and support. Join us in raising awareness as we #GoGrayInMay

#Breakingnews: In a MAJOR step forward, the FDA has approved the first targeted treatment for pediatric pLGG, the most common pediatric brain cancer. Congratulations, @DayOneBio and Sam Blackman, Day One Founder and a member of our Board of Directors! lnkd.in/ebsWFpNa